drugset / Trial / NCT00333164
Cilostazol-Aspirin Therapy Against Recurrent Stroke With Intracranial Artery Stenosis
Phase 3
Completed
200 enrolled
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
China National Center for Cardiovascular Diseases · collabDepartment of Neurology, Saiseikai Central Hospital · collabFoundation for Biomedical Research and Innovation · collabKobe City General Hospital · collabKyushu University · collabNeurology, Tokyo Women's Medical University, School of Medicine · collabTohoku University · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Multi-center, open-labelled randomized controlled trial, to study the effect of aspirin plus cilostazol and aspirin alone on the progression of intracranial arterial stenosis, in 200 chronic stroke patients with 50-99% stenosis, to be followed up for 2 years
Timeline
- Start
- 2006-05
- Primary completion
- 2012-03
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cilostazol | Small molecule | 200 mg | — |
| Background | Aspirin | Small molecule | 100 mg | — |